Purchases and Sales Made in Q2 2022 in Vaxcyte, Inc. (PCVX)
This table provides information about the institutional ownership of Vaxcyte, Inc. (PCVX) during Q2 2022. The information is specifically focused on institutions that hold shares of Vaxcyte, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 14, 2024
Q2 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-128K- 26.55% |
$2.26M - $3.4M
|
353K
$32M
|
|
|
Aug 12, 2022
Q2 2022
|
Pivotal Bio Venture Partners Investment Advisor LLC
San Francisco, CA |
SELL
|
- |
-279K- 25.13% |
$4.94M - $7.42M
|
832K
$75.3M
|
|
|
Aug 15, 2022
Q2 2022
|
Tpg Gp A, LLC
Fort Worth, TX |
SELL
|
- |
-365K- 9.01% |
$6.46M - $9.71M
|
3.69M
$334M
|
|
|
Aug 10, 2022
Q2 2022
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
SELL
|
- |
-522K- 22.61% |
$9.23M - $13.9M
|
1.79M
$162M
|
|
|
Aug 15, 2022
Q2 2022
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-1.02M- 88.71% |
$18M - $27M
|
129K
$11.7M
|
|
|
Aug 15, 2022
Q2 2022
|
Eco R1 Capital, LLC
San Francisco, CA |
SELL
|
- |
-1.3MClosed |
$23.1M - $34.7M
|
0
$0
|